跳至主要内容
临床试验/NCT07469761
NCT07469761招募中不适用

MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care

Augusto Caraceni1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年11月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
1
主要终点
Change in overall symptom burden assessed by the ESAS.

研究概览

简要总结

The goal of this clinical trial is to learn whether a structured, Patient-Reported Outcome Measures (PROMs)-tailored palliative care pathway improves clinical outcomes and care experience in adults with advanced cancer referred to outpatient palliative care.

Patients with advanced cancer often experience multiple symptoms and complex needs. Standard outpatient palliative care is usually guided by clinical judgment on patient-reported questionnaires. In this study, researchers aim to test whether a more structured approach, based on predefined cut-offs from PROMs, can improve symptom control, satisfaction with care, and use of healthcare resources. The main questions the study aims to answer are:

Does a structured, PROM-driven palliative care pathway reduce symptom burden and psychological distress compared with usual care? And through this, to improve patients' and caregivers' satisfaction with care or reduce emergency room visits, hospital admissions, healthcare costs, and aggressive treatments near the end of life?

Researchers will compare two groups:

Control group: Participants will receive standard outpatient palliative care. PROMs are collected as usual, but without predefined cut-offs or structured intervention checklists.

Experimental group: Participants will receive a structured palliative care pathway tailored to symptoms/needs identified at baseline using PROM cut-offs. Specific multidisciplinary interventions are activated according to identified needs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of advanced/metastatic cancer
  • age > 18
  • Eastern Cooperative Oncology Group (ECOG) performance status ≥2
  • prognostic clinical prediction >1 month.

排除标准

  • Serious medical or psychiatric illness that can interfere with informed consent and participation in this clinical study
  • any condition that is unstable or could jeopardize the safety of the patient and their compliance in the study.

研究组 & 干预措施

Structured interventions tailored to PROMs cut-off

Experimental

• Experimental group, which will follow a structured palliative care pathway (specific intervention defined in the protocol) based on the frailties identified at baseline PROMs (defined by cut-off).

干预措施: Structured Palliative Care (Other)

Classic Palliative Car interventions

Active Comparator

• Control group, which will undergo standard unstructured palliative care (based on PROMs as usual, but without cut-off or interventions' checklists)

干预措施: Classical Palliative Care (Other)

结局指标

主要结局

Change in overall symptom burden assessed by the ESAS.

时间窗: 1, 3 months

\- Mean change in symptom burden from baseline to 1 month after initiation of palliative care, measured using the Edmonton Symptom Assessment System (ESAS) total score (range 0-90, higher scores indicating greater symptom burden). The analysis will compare the change in ESAS total score between the two randomized groups.

Change in psychological distress assessed by the Distress Thermometer (DT).

时间窗: 1, 3 Months

Mean change in psychological distress from baseline to 1 month after initiation of palliative care, measured using the Distress Thermometer (DT) (range 0-10, higher scores indicating greater distress). The analysis will compare the change in DT score between the two randomized groups.

次要结局

  • Patients' satisfaction with care(1, 3 months)
  • Healthcare resource utilization(3, 6 months)
  • Differeces in End of Life (EoL) care aggressiveness criteria(3, 6 months)
  • Caregivers' satisfaction with care(1, 3 months)

研究者

发起方
Augusto Caraceni
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Augusto Caraceni

Professor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

研究点 (1)

Loading locations...

相似试验